Fig 1.
Flowchart of patient selection for this study.
GV, gastric varices; HE, hepatic encephalopathy; BRTO, balloon-occluded retrograde transvenous obliteration; EV, esophageal varices; PSS, portosystemic shunt.
Table 1.
Baseline clinical characteristics of patients.
Table 2.
Causes of death after BRTO.
Fig 2.
(a) Overall survival after BRTO, (b) Cumulative incidence of liver-related events after BRTO.
BRTO, balloon-occluded retrograde transvenous obliteration; LREs, liver-related events.
Fig 3.
Cumulative rates of EV deterioration after BRTO.
BRTO, balloon-occluded retrograde transvenous obliteration; EV, esophageal varices.
Table 3.
Predictive factors of EV deterioration after BRTO.
Fig 4.
Comparison of the cumulative rates of EV deterioration after BRTO according to (a) Sex, (b) Preoperative Platelet Count, and (c) EV Before BRTO.
BRTO, balloon-occluded retrograde transvenous obliteration; EV, esophageal varices.
Fig 5.
Cumulative rates of EV deterioration based on score.
EV, esophageal varices.
Fig 6.
Comparison of postoperative clinical course between two patients with different prediction scores for EV deterioration after BRTO.
The patient with a score of 3 shown in underwent esophagogastroduodenoscopy every 6 months, which allowed early detection of EV deterioration and prophylactic treatment. BRTO, balloon-occluded retrograde transvenous obliteration; EV, esophageal varices; ALD, Alcohol-associated liver disease; EIS, endoscopic injection sclerosis; RC, Red color.